A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology

Lysosomes have fundamental physiological roles and have previously been implicated in Parkinson’s disease 1 – 5 . However, how extracellular growth factors communicate with intracellular organelles to control lysosomal function is not well understood. Here we report a lysosomal K + channel complex t...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 591; no. 7850; pp. 431 - 437
Main Authors Wie, Jinhong, Liu, Zhenjiang, Song, Haikun, Tropea, Thomas F., Yang, Lu, Wang, Huanhuan, Liang, Yuling, Cang, Chunlei, Aranda, Kimberly, Lohmann, Joey, Yang, Jing, Lu, Boxun, Chen-Plotkin, Alice S., Luk, Kelvin C., Ren, Dejian
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 18.03.2021
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Lysosomes have fundamental physiological roles and have previously been implicated in Parkinson’s disease 1 – 5 . However, how extracellular growth factors communicate with intracellular organelles to control lysosomal function is not well understood. Here we report a lysosomal K + channel complex that is activated by growth factors and gated by protein kinase B (AKT) that we term lysoK GF . LysoK GF consists of a pore-forming protein TMEM175 and AKT: TMEM175 is opened by conformational changes in, but not the catalytic activity of, AKT. The minor allele at rs34311866, a common variant in TMEM175 , is associated with an increased risk of developing Parkinson’s disease and reduces channel currents. Reduction in lysoK GF function predisposes neurons to stress-induced damage and accelerates the accumulation of pathological α-synuclein. By contrast, the minor allele at rs3488217—another common variant of TMEM175 , which is associated with a decreased risk of developing Parkinson’s disease—produces a gain-of-function in lysoK GF during cell starvation, and enables neuronal resistance to damage. Deficiency in TMEM175 leads to a loss of dopaminergic neurons and impairment in motor function in mice, and a TMEM175 loss-of-function variant is nominally associated with accelerated rates of cognitive and motor decline in humans with Parkinson’s disease. Together, our studies uncover a pathway by which extracellular growth factors regulate intracellular organelle function, and establish a targetable mechanism by which common variants of TMEM175 confer risk for Parkinson’s disease. The identification of a lysosomal K + channel complex—comprising AKT and the pore-forming TMEM175—provides insights into the mechanisms through which variants of the pore-forming protein affect the development of Parkinson’s disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions J.W. performed all the electrophysiology studies, the neuronal damage analysis, the α-syn PFF seeding assay, galectin 3 assay, BODIPY–pepstatin A assay, autophagosome fusion assay and pH imaging in Fig. 5a and Extended Data Figs. 8–10. Z.L. and J.W. carried out the protein chemistry, RT–PCR analysis and S2 cell Akt knockdown studies. K.A., J.L. and D.R. developed cDNA constructs and mouse lines. C.C. performed earlier exploratory recordings that demonstrated that the TMEM175-knockout lysosomes lack TMEM175 currents and that SC79 activates TMEM175. Y.L. and K.C.L. performed TH immunostaining comparing the wild-type and homozygous mouse brains, and prepared and validated the α-syn PFFs. L.Y., H.W. and J.Y. performed the whole-tissue immunolabelling, optical clearing and light-sheet 3D imaging analysis comparing the wild-type and heterozygous mouse brains. H.S. and B.L. performed the mouse behavioural studies. T.F.T. and A.S.C.-P. carried out the clinical studies. D.R., J.W., B.L., J.Y., A.S.C.-P. and K.C.L. designed experiments and wrote the manuscript with contributions from all the authors.
ISSN:0028-0836
1476-4687
1476-4687
DOI:10.1038/s41586-021-03185-z